Degrees Pharmaceuticals (SXTP) announced that it will effect a 1-for-5 reverse stock split of its common stock. The common stock will ...

Innate Pharma shares were up 16% to $2.25 after the company said the Food and Drug Administration has granted Breakthrough Therapy Designation to lacutamab for the treatment of adult patients with ...

Explore Sun Pharma Industries stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn’t one of them. The 10 stocks that ...

A bipartisan coalition of states, including Tennessee, will receive $7.4 billion from Purdue Pharma, Inc. and members of the Sackler family for their “instrumental” role in the crisis.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

That is why the $7.4 billion settlement by Purdue Pharma is so important. Purdue Pharma, owners could pay $7.4 billion in new settlement over toll of OxyContin Connecticut will get more than $60 ...

NEW YORK (Reuters) - Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company's years-long effort to resolve thousands of ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Bankrupt Purdue Pharma and its owners have agreed to pay $7.4 billion (€7.1 billion) to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...